Continuous Administration of the mTORC1 Inhibitor Everolimus Induces Tolerance and Decreases Autophagy in Mice

British Journal of Pharmacology - United States
doi 10.1111/bph.13626
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Wiley

Related search

Efficacy of the Oral mTORC1 Inhibitor Everolimus in Relapsed or Refractory Indolent Lymphoma

American Journal of Hematology
Hematology
2017English

the mTORC1 Inhibitor Everolimus Prevents and Treats Eμ- Myc Lymphoma by Restoring Oncogene-Induced Senescence

Cancer Discovery
Oncology
2012English

Potentiation of the Anticancer Effects of Everolimus Using a Dual mTORC1/2 Inhibitor in Hepatocellular Carcinoma Cells

Oncotarget
Oncology
2016English

Endurance Exercise Induces REDD1 Expression and Transiently Decreases mTORC1 Signaling in Rat Skeletal Muscle

Physiological Reports
Physiology
2014English

TP53BP2 Decreases Cell Proliferation and Induces Autophagy in Neuroblastoma Cell Lines

Oncology Letters
Cancer ResearchOncology
2019English

Angiopoietin-Like Protein 4 Decreases Blood Glucose and Improves Glucose Tolerance but Induces Hyperlipidemia and Hepatic Steatosis in Mice

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2005English

A New Generation of mTORC1 Inhibitor Attenuates Alcohol Intake and Reward in Mice

Addiction Biology
MedicinePsychiatryMental HealthPharmacology
2017English

Non‑covalent Proteasome Inhibitor PI‑1840 Induces Apoptosis and Autophagy in Osteosarcoma Cells

Oncology Reports
MedicineCancer ResearchOncology
2019English

FAK and S6K1 Inhibitor, Neferine, Dually Induces Autophagy and Apoptosis in Human Neuroblastoma Cells

Molecules
Organic ChemistryMolecular MedicineAnalytical ChemistryTheoretical ChemistryPharmaceutical ScienceMedicineDrug DiscoveryChemistryPhysical
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy